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Abstract
The heart is a major organ whose function is to transport nutrients and waste throughout the
body. This organ can become infected by pathogens, such as viruses, bacteria, or parasites.
Infection of the middle heart layer, or myocardium, is often caused by a viral agent. This disease
has three stages: viral infiltration, adaptive immune system activation, and finally either viral
clearance or cardiac cell remodeling. During this process the immune system will begin to
secrete cytokines, which are signaling molecules that alert other members of the immune
pathways, and also participate in cardiac remodeling. Evaluating the correlation between the
cytokine expression levels with the viruses present in cardiomyopathy-positive heart tissue
samples can lead to a better understanding of cardiac disease process, and aid in the development
of new diagnostic tools.
In order to accomplish this study nucleic acid (DNA and RNA) from heart tissues obtained from
cardiomyopathy-positive samples, as well as donor samples, was isolated. The DNA was then
used in a PCR reaction with viral primers corresponding to DNA viruses. Next, RNA was used
to synthesize cDNA. With cDNA made two types of analyses took place: a PCR with primers
specific to RNA viruses was performed to identify viral genomes, and a qPCR assay was done to
evaluate the expression levels of cytokines.
The most common viruses identified in the study were HRSV, Herpesviruses 5/7, and HepatitisC virus. The virus that was least prevalent was Coxsackievirus-B3. The analysis of cytokine
expression profiles and genes involved in cardiac remodeling revealed that samples BIF28 and
48CAF had the highest expression levels of immune system, and cardiac, markers. The two
markers with increased expression levels were Tnnt2 and TGF-β. When the cytokine expression
levels were compared for each of the three heart layers (endocardium, epicardium, and
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myocardium) it was seen the epicardium had the highest expression levels, suggesting highest
levels of inflammation. In sum, the generated data revealed a correlation between viral infection
and the degree of heart inflammation. Interestingly, based on samples analyzed in this study, I
showed that distinct layers of the heart can have various inflammatory profiles, suggesting
different levels of cardiac damage. Follow up studies will help delineate the association of viral
infection of cardiac muscle and inflammation, which may help develop better diagnostic tools.
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Introduction
The heart is a major organ within the human body, whose main function is to act like a pump (1).
This pump is in charge of collecting deoxygenated blood from the body and transporting it
through the veins to the lungs (1). In the lungs the blood becomes reoxygenated, which allows
the heart to pump this blood to the tissues in the body (1). During this process, nutrients,
hormones, and waste products are also transported throughout the body to the correct tissues (1).
The anatomical structure of the heart consists of 4 general regions: the right and left ventricle
along with the left and right atrium (1). These regions are all connected through various valves
preventing backflow of blood. There are also three main cellular levels within the heart, the
epicardium, the outer most layer, the myocardium, the middle most layer, and the endocardium,
the innermost layer (1). Cardiac muscle cells, otherwise known as cardiomyocytes, make up
between 70 to 85 percent of the volume within the heart (1). The other cells known to make up
the human heart are fibroblasts, endothelial cells, and peri-vascular cells (22). These other cell
types ensure that the cardiomyocytes can contract properly and thus allow for the survival of the
individual by building up the extracellular matrix and allowing intercellular communication (22).
The endothelial cells outnumber cardiomyocytes; however, they are located very close to the
cardiomyocytes, leading to the conclusion that the endothelial cells trigger the response to stress,
and help regulate heart contraction (22). Fibroblasts are not very abundant in the human cells,
and they aid heart remodeling and arrhythmogenesis (22). Like all other cells in the body, the
cardiomyocytes are prone to infection. When these cells become infected by a pathogen, such as
a virus, a bacterium or a parasite, heart disease may develop (2).
In the United States heart disease is the leading cause of death, with an average 1 out of every 4
deaths being attributed to a heart condition (2). Some of the more common heart diseases are
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heart valve disease, in which at least one of the valves malfunctions, pericardial disease affecting
the pericardium of the heart, and coronary heart disease affecting the arteries within the heart (2).
The key factors that lead to heart disease are high blood pressure, high cholesterol levels, and
smoking (3). These factors, and many more, lead to plaque built up in the arteries preventing
proper blood flow throughout the body (3). When a virus infects the myocardium in the heart
then this is known as myocarditis.
The proper function of the myocardium is to ensure heart contraction (4). This layer is able to
generate force through cardiomyocytes communicating with each other via gap junctions (4). In
a majority of cases myocarditis will be asymptomatic, not requiring any intervention, but in
severe cases the heart is permanently damaged resulting in heart failure, stroke, or death (5). To
diagnose myocarditis a doctor will order an MRI to detect any heart inflammation, use a blood
test to determine the immune response, and an electrocardiogram to detect an abnormal heartbeat
(6). In the blood test it is often that the levels of Troponin-I are evaluated given it is 89 percent
specific in diagnosing myocarditis in patients (7). However, this biomarker is only 34 percent
sensitive in the diagnosis of myocarditis displaying the need to further develop better diagnostic
tools. Troponin is a regulatory protein that controls the interaction between actin and myosin in
the myocardium. (18). It has been noted that nearly all patients have had elevated levels of
cardiac troponin, cTn1, during a viral infection (18). On the electrocardiogram, a device
measuring electrical signals in the heart, often the Q waves and St waves are evaluated (8). This
is because in 27 percent of deaths these two waves are upregulated (8). In more severe cases, a
heart biopsy sample will be obtained, but the American Heart Association and American College
of Cardiology require that this approach is only taken after the onset of heart failure, and if the
patient’s left ventricle have become dilated (9).

Viral Induced Myocarditis

8

The pathophysiology of myocarditis is broken down into three distinct parts. The first part of this
process is known as acute myocarditis, which typically lasts for one week and involves viral
entry into the heart (23). For this to happen a virus, such as a Coxsackievirus, binds to a receptor
on a cardiomyocyte (23). The receptor in this case is DAF (23). This viral entry first triggers the
innate immune response, which involves cells such as the natural killer cells and macrophages
(23). This results in myocyte breakdown through protease apoptosis (23). The innate immune
response also results in cytokine expression, especially Interleukins 1 and 2 (Il-1, Il-2), Tumor
necrosis factor alpha (TNFα), and Interferon gamma (23).
The second phase of myocarditis is known as the subacute phase. In this phase the adaptive
immune system is activated, which results in the upregulation of B cells and T cells, as well as in
the production of cardiac autoantibodies (23). This leads to the heart tissue becoming inflamed
causing more damage to the patient (23). The subacute phase lasts between 1 to 4 weeks. The
final phase is known as chronic myocarditis, or viral clearance. In this phase the virus has either
been properly cleared from the body resulting in normal heart function, or the heart has not been
unable to clear the virus (23). This failure to clear the viruses results in chronic inflammation
(23). When the heart is inflamed for an extended period of time the myocytes are degraded and
the heart cells are remodeled (23). If this is not treated the patient’s heart will fail, requiring a
transplant to avoid death.
The immune system response in the heart is similar to that in the rest of the body, and it involves
both an innate and an acquired pathway. The innate immune system is nonspecific (10), and it
consists of barriers such as the skin and cilia, white blood cells, and other proteins (10). Many of
the cells of the innate immune system, such as the natural killer cells, use enzymes in order to
break down the virus infected cells (10).
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The adaptive immune system is activated if the innate immune system is unable to properly clear
the virus from the cells. The adaptive immune system is made up of the T-lymphocytes and Blymphocytes. B-lymphocytes are produced and mature within the bone marrow (10). B-cells
communicate with many nearby cells, as they lead to the secretion of cytokines, and are activated
by T-cells (10). Once a virus has been properly dealt with, memory cells are created to ensure the
body is prepared if the pathogen ever reinfects an individual (10). T-cells are also created in the
bone marrow, but they mature in the thymus. There are three main types of T-cells in the body,
the cytotoxic T-cells which break down the infected cells, the T-helper cells which recognize
infected cells and activate B-cells, and the T-memory cells which are activated if a pathogen ever
reinfects the individual (10).
During this immune response small specific proteins, known as cytokines, are activated (11).
These cytokines are able to have an effect on the cells that secreted the nearby cells, and also
cells from all over the body (11). In the event that the immune system is overactive, a
proinflammatory response known as a cytokine storm can result (11). If the immune system
continues to be upregulated, then this could result in the death of a cell (11). Some of the
cytokines known to cause this inflamed response in the heart are TNF- α, TGF-β, IL-1, IL-4, IL6, IL-8 and IL18 (12). Additionally, not all cytokines are detrimental, and it has been determined
that the following cytokines: IL-2, IL-4, IL-6, IL-8, IL-10, are beneficial when it comes to
clearing virus infected cells.
Some of the known viruses known to cause myocarditis are Herpesviruses (including Human
Herpesvirus 6 and Epstein-Barr virus), Parvovirus, Hepatitis-C, Shingles, HRSV, Adenovirus,
and more recently, Covid-19. Herpesvirus is of high importance because it is estimated that 95
percent of adults worldwide are infected with Herpesvirus-1 (HSV1) (13). More generally,
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Herpesvirus is a latent virus meaning that viral DNA inserts itself in the hosts’ nucleus and
replicates along with the hosts cells (13). Herpesvirus has a genome size of around 250 kilobase
pairs and four structural components (13). These are the capsid, envelope, tegument, and
glycoprotein spike (13). Another important factor in dealing with Herpesviruses is that there is
no known cure for this disease, and only treatments that result in the temporary prevention of
symptoms are currently available (14).
Another type of Herpesviruses that is known to cause myocarditis is Epstein-Barr virus (EBV)
(15). This virus targets the adaptive immune system within the body working to infect the Blymphocytes (15). Over time EBV is able to infect T-cells and natural killer cells resulting in
hemophagocytic lymphohistiocytosis (15). What makes this virus different from most types of
Herpesviruses is that it is only ever active at low levels in the body, remaining inactivated a
majority of the time (15). EBV encodes for the proteins BZLF1 and BRLF1, which are known to
enable cell destruction assisting in the virus’s negative effect on the patient (15).
A second virus known to cause myocarditis is Adenovirus (16). This virus is double stranded
DNA-based with a total diameter of 100 nm (16). To date, there are 67 known strains of
Adenoviruses with new sub-types often being found given the high mutation rate of this virus
(16). The outside component of this virus contains a coat with 20 triangular faces (16). This virus
family enters the cell through the CAR receptor and once inside cardiomyocytes, the infection
results in cytoskeletal disruption creating an uncontrolled immune response even after the viruses
has been cleared from the cell (24). Over time, the infection with these viruses, or viral
persistence, may result in left ventricle dysfunction (24).
Parvovirus is another DNA virus that results in anemia due to the effect the virus has on red
blood cells (17). Parvovirus is often referred to as the filth disease, which often affects young
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children (17). This disease results in a mild rash for many individuals and is spread within the
patient’s albumin and immunoglobulins (17). Parvovirus has been seen to infect endothelial cells
resulting in cardiomyocyte apoptosis (24). This particular disease is interesting as it can be found
in autopsy samples from people who were not positive for myocarditis suggesting that the viral
presence may not necessarily indicate a disease process (24).
Another group of viruses that has been known to historically cause myocarditis is the
Coronaviridae family. The latest example of a virus from this family that has been able to do this
is SARS-CoV-2. This virus is able to damage the heart through an imbalanced immune response
(24). This excess of T-helper cells triggers a cytokine storm that leads to myocardial damage
(24). SARS-CoV-2 has been able to enter the cell through a ACE2 receptor which in turn
decreases the levels of angiotensin in the heart (24). In lab however it is unlikely that this strain
will be found due to the fact the samples have been collected before the pandemic, but this virus
displays the need to test the samples for other viruses in the Coronaviridae family. Some of the
other known coronaviruses are HCoV-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU (25).
Interestingly, myocarditis can infect anyone regardless of age, but children often present
different symptoms than adults. Some of the symptoms seen in children who are diagnosed with
myocarditis are poor appetite, cyanosis, and anxiousness (19). Children are also more likely to
have sudden death due to the disease and a more severe onset of symptoms (19). Also, in a
majority of cases a heart transplant is required (19). It has also been noted that children often
have a much higher cytokine expression patterns when exposed to the virus, and more viruses are
often found in the heart tissue at one time (20).
In order to treat myocarditis, the first step is to use corticosteroids (21). These are medications
that suppress the patient’s immune system decreasing the inflammation seen in the heart (21).
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This type of treatment is most effective in giant cell and eosinophilic myocarditis (21). Other
medications that are often used are diuretics to help regulate blood osmolality, beta blockers to
decrease the blood pressure, ACE inhibitors and angiotensin II blockers which are important to
prevent angiotensin (a substance that narrows blood vessels) from being produced (21).
In more severe cases procedures will be used to help the heart pump blood more efficiently. One
example of this is a ventricular assist device, which helps the ventricles pump blood throughout
the body (21). Similarly, in the case of heart failure an ECMO extracorporeal membrane
oxygenation machine mimics the lungs by removing carbon dioxide from the blood and adding
oxygen (21). If none of the above procedures work, a heart transplant is required to keep the
patient alive. Therefore, it is the goal of this study to create a diagnostic tool to screen patients
for myocarditis through the identification of viruses present in human heart samples and the
subsequent determination of the cytokine expression levels.
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Materials and Methods
This study sought to use human heart tissues to identify the cytokine expression level pathways
associated with viral infection. Then using this correlation, the aim was to define pathological
features related to the damage seen in the heart samples. To accomplish this, genetic material
from the human heart samples was isolated. These heart samples were isolated from patients who
have been suffering from heart inflammation. The nucleic acid (DNA and RNA) from these
samples was isolated and used in subsequent qPCR assay to determine the cytokine expression
levels in each sample. This assay will be complemented with histological examination to clearly
show the cardiac damage.
Nucleic Acid (DNA/RNA) Isolation from human heart tissue samples
To investigate how viral infection affects the cytokine expression patterns, I evaluated human
heart biopsy samples obtained from the Campbell Muscle Lab at the University of Kentucky, and
the Gill Heart & Vascular Institute in Lexington, Kentucky. All samples utilized in this analysis
were excised from the hearts of patients diagnosed with either dilated cardiomyopathy or
myocarditis. ZYMO DNA/RNA purification kit (Zymo Research) was used to derive DNA and
RNA, with minor modifications. In order to accomplish the nucleic acid extraction, small pieces
(>5 mg) of individual human heart tissue samples were isolated, and then homogenized in a
solution containing appropriate ZYMO Tissue Kit buffers. This step typically yielded over 100
ng of DNA per sample, allowing for downstream assays to be conducted properly. RNA was
than extracted using specific spin columns. This process began with an initial centrifugation that
bound the RNA to the filter column, followed by the intermittent centrifugation and removal of
flow through of the following buffers: DNA/RNA Prep Buffer and two rounds of DNA/RNA
Wash Buffer. The amount of eluted RNA was usually over 500 ng per µl in each sample.
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Estimation of DNA/RNA quality and quantity using a spectrometer and agarose gel
electrophoresis
The extraction of the nucleic acid was then confirmed through gel electrophoresis with bands
corresponding to the sizes of DNA and RNA extracted. The agarose gel was made with Tris
acetate EDTA, TAE, and water were used to dissolve agarose at high temperatures. Then Safe
DNA stain from the Thermo Fisher Scientific gel electrophoresis kit was added to the mixture
and it was allowed to cool in a gel plate. Once cool the DNA/RNA samples were mixed with 6X
DNA loading dye which was then added to the wells of the gel with a DNA ladder. A negative
current was applied to the gel so that the samples would migrate through the gel. Once the
markers have migrated the appropriate distance the gel was visualized. The DNA band was then
compared to the ladder to evaluate if it has been properly isolated. For the RNA three bands were
expected to be seen, corresponding to 28S, 18S, and tRNA.
While this was happening the DNA and RNA was the quantified using the nanodrop. For this
procedure to work, 2µl of sample was added to the nanodrop plate along with 2µl of blank which
was DNA/RNAse free water in this case. This procedure allows for the concentration to be
known by measuring the amount of light that was not absorbed by the samples and quantifying
that number.
Next, the purity of each of the extracted nucleic acids was also determined. This was done by
seeing how much light of wavelength 260nm and 280nm has been absorbed by the samples.
Then the ratio of 260nm wavelength absorbed was compared to the amount of 280nm light that
has been absorbed. The expected ratio of 260/280 would be approximately 1.8 for DNA and 2.0
for RNA as these ratios correspond to “pure” nucleic acids, which was what was seen in a
majority of the cases.
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PCR analysis with virus specific primers
Following the nucleic acid extraction, I performed PCR analysis with primers specific to viruses.
The reagent kit used was Thermo Scientific Phusion DNA Polymerase. For this reaction the
sample was added into a tube with various reagents, primers, sample, and the DNA polymerase
enzyme. The primers chosen for DNA samples were for known DNA viruses previously shown
to be linked to heart disease (Adenovirus, Parvovirus-B19, Epstein-Barr virus, Varicella-Zoster
virus, herpes simplex 1 virus and cytomegalovirus). Next, the samples were put in the
thermocycler. For each virus slightly different conditions were used to optimize product yield
and purity.
For the RNA an extra step was required. This was to synthesize cDNA from the total RNA
samples. This began by using the ThermoFisher Scientific DNase I treatment to remove any
excess DNA in the sample. Next, cDNA synthesis mix was made with reagents from the
SuperScript III First-Strand Synthesis System for RT-PCR kit. This mixture was then added to
the samples which contained RNA that has been previously incubated with random hexamers
and dNTPs. The samples were then placed in the thermocycler where they were subjected to 25
degree Celsius for ten minutes, 50 degrees Celsius for 50 minutes, and 85 degrees Celsius for
five minutes. With the cDNA synthesized primers for RNA viruses that are known to cause
myocarditis, such as Coxsackievirus-B, EMCV, Influenza viruses or Scaffold viruses were used.
This was done with the same procedure as seen above.
The products of both PCR’s were then then run on an agarose gel, as described above. During
the visualization of the gel, it was expected to see one band that corresponds to the viral genome
being analyzed for. If no band was seen, then that sample likely was not positive for that
particular virus.

Viral Induced Myocarditis

16

Quantitative PCR (qPCR) analysis of immune system and cardiac gene expression in
selected human heart tissue samples
Using the RNA samples, the cytokine expression levels were also determined. This was done by
first converting the RNA into cDNA. The detailed procedure for this can be seen in the section
above. With the cDNA synthesized this samples were then used to evaluate the cytokine
expression levels, using the ThermoFisher Real-Time PCR Applied Biosystem SYBR kit. Using
the reagents within this kit and primers for cytokines associated with myocarditis (NF-κB, TGFβ, IL-10, IL-1β, IL-6, TNF-α, CRP, IL-1RA, MAPK, IL-18, (MCP)-1/CCL2, IL-8/CXCL8). This
mixture was then pipetted into the wells on the qPCR plate. Using the cycler, the samples were
exposed to the manufacturer's conditions of 98 degrees Celsius for 30 seconds, then 37 cycles of
98 degrees Celsius for 10 seconds, 60 degrees Celsius for 30 seconds, and 72 degrees Celsius for
30 seconds. The cycle then ended with the samples being heated to 72 degrees Fahrenheit for 30
seconds.
After the cycle was completed, the data was exported from the computer for processing. All
measurements were compared to actin levels allowing for normalization. Actin was used for
normalization as it is a housekeeping gene expressed in all tissues normally. Using this data
graphs were constructed to compare the expression levels of the various markers evaluated.
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Results
Through the evaluation of cytokine expression levels, and viruses present in myocarditis-positive
heart tissue samples it is theorized that myocarditis diagnostic tool can be developed. At the
beginning of this experiment many of the samples were given an ID number to help with
identification. These samples were then compiled in a table, where the cause of death for each
individual and any additional comments from the doctors were added. This can be seen below.
Table 1: Isolated Heart Samples IDS and corresponding patient health information

Using this table, it has been seen that the leading cause of death was heart failure, furthering the
evidence that there is an underlying immune system issue causing the patient’s heart to
malfunction.
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Once the DNA was extracted, a PCR was conducted using viral primers. This was done for all of
the samples. Next, the DNA was run on a band where a sample that was positive for the sample
will see a band within the gel corresponding to the size of the viral genome. The viruses
identified in each sample can be seen in the image below (table 2).
Table 2: Viruses identified in each human heart sample

With the viruses identified, the cytokine expression levels were then determined to evaluate the
molecular profiles of heart damage. To do this, RNA was isolated from each sample and
converted to cDNA. This cDNA was used in the qPCR assay with cytokine primers so the
inflammation levels of each heart sample could be evaluated. The first trials were done with 2
organ donor heart samples from patients who did not have myocarditis, and 8 myocarditis/
dilated cardiomyopathy-positive samples. The two donor samples were 4D931 and 2B487, while
the six experimental samples were 063A3, 63513 7E551, E98EE, 48CAF, BOBD1, EOABF, and
BIF28. The results from this analysis can be seen below (figure 1+2):
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Figure 1: Relative fold expression profiles of NF-kβ, TGF-β and Rig-1 in organ donor samples
and cardiomyopathy samples
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Figure 2: Relative fold expression profiles of Tnnc1 and Tnnt2 in organ donor samples and
cardiomyopathy samples
Next, using RNA extracted from three samples, 632FD, 59386, and 48CAF, the inflammation of
each of the heart layers was determined. This analysis can be seen below (figure 3+4):
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Figure 3 Relative fold expression profiles of Tnnc1, CRB, and Interleukin-6 in the three heart
regions of cardiomyopathy samples
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Figure 4 Relative fold expression profiles of NF-κB, Rig-1, and Interleukin-18 in the three heart
regions of cardiomyopathy samples
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Discussion
Each year in the United States, 1 in 4 causes of death can be attributed to heart disease, making it
the leading cause of death. One cause of heart disease is myocarditis, which is the inflammation
of the middle heart layer, myocardium. Viruses are thought to be responsible for most of the
myocarditis cases. It is important to understand how these viruses contribute to myocarditis as
the myocardium is essential for the heart to properly contract (4). In severe cases, myocarditis
will lead to the heart being permanently damaged, causing the patient to have a stroke, heart
failure, or at its worse die (5).
It has been seen that the progression of myocarditis can be broken into three distance phases. The
first is acute myocarditis, when a virus can insert its genome into the heart, activating the innate
immune system (23). During this phase, cytokines begin to be expressed, causing the heart to
become inflamed (23). In the second phase, the subacute phase, the adaptive immune system
becomes activated within the heart (23). This phase of myocarditis will last four weeks at its
longest, and once again, the heart becomes further inflamed, which adversely affects the patient
(23). In the third phase, the viruses are either cleared from the heart, and the patient returns to
normal, or the viruses remain in the heart leading to chronic inflammation (23). During this time
of increased inflammation, the myocytes begin to become remodeled, resulting in heart failure
(23). It is important to understand the mechanism of each virus so that treatments or diagnostic
tools can be created to help save the lives of many. For example, a doctor could better treat a
myocarditis-positive patient if they could determine which virus was causing the condition and
that virus’s mechanism.
For many viruses evaluated in this study, the pathogenic mechanisms and site of cardiac
infection are currently unknown. When it comes to enteroviruses (such as Coxsackievirus B3), it
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has been seen that these viruses attack the heart as a secondary target organ (26). This happens
because when one of these viruses infect the host through the gastrointestinal or respiratory tract
and form an extracardiac reservoir (26). Then the viruses are recruited to the heart tissues,
breaking down the cardiomyocytes (26).
Parvovirus, however, has a very different mechanism that starts with this virus infecting the
vascular endothelial cells (26). Most people are exposed to these viruses when they are children,
and then these viruses asymptomatically form reservoirs in the bone marrow (26). It has been
seen in cases of myocarditis that this virus has been localized in the endothelial cells of venules,
small arteries, and the arterioles (26). Parvovirus is released from the bone marrow by infected
capillary cells and then induced damage of the endothelial cells by a direct cell virus interaction
(26).
Herpesviruses have been found to affect several regions of the human heart, including the
myocardium, left ventricle, and right ventricle. This virus has been able to infect both the
mononuclear and endothelial cells (26). It further has been seen that cardiac myocytes and
endothelial cells are reservoirs for latency and reactivation (26). Additionally, herpesviruses,
specifically human herpesvirus-6 is reactivated by other infections (26). This leads to the theory
that this virus enhances the pathogenicity of other viruses instead of being the main pathogen
itself (26). It has been seen that human herpesvirus-6 is present in 50% of the progenies (26).
Epstein-Barr virus is another virus from the herpesvirus family. The mechanism of this particular
virus is that it infects the cells of the adaptive immune system. It begins by infecting the B-cells
and epithelial cells (15). What is unique to this virus is that it is usually active in the cells of the
body at very low levels meaning it is likely also enhancing the pathogenicity of other viruses
(15). Epstein-Barr viruses’ main effect on patients is that the EBV genome encodes for two
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proteins BZLF1 and BRLF1, which will lead to cell destruction, further affecting any
myocarditis-positive patient (15).
Another virus that is often found in cases of myocarditis is Adenovirus. This virus is a very
common source of infections in humans (common cold), and its high mutation rate makes it
more difficult for the immune system to properly clear (16). The Adenoviridae family of viruses
is able to enter cardiomyocytes through the CAR receptor on the outside of the cell (16). Once
the virus has entered the cell, it causes cytoskeletal disruption (24). This disruption leads to an
uncontrolled immune system response, causing dysfunction of a patient’s heart’s left ventricle.
This research project aimed to identify viruses in human heart tissue by examining samples
obtained from patients suffering from myocarditis or dilated cardiomyopathy, and to establish an
inflammatory gene expression profile in these samples. A series of donor samples were included
in this analysis to further learn about the molecular characteristics of the immune system
response to viral infection. It was seen that Tnnc1 and Tnnt2 had an over 2 relative fold change
in a majority of samples, which is considered upregulated (Figure 2). When compared to the
other cytokines, it was seen that CRB, and Interleukin-6 is had a low expression profile with
under a 0.5 relative fold change (Figure 2+3). Interleukin-6 is of particular importance as it is a
proinflammatory cytokine that, over time will lead to the breakdown of both the cytokine
network and viral clearance pathways (27). Given it has a relatively low expression level, it is
theorized that the virus might not be actively replicating in these samples, despite viral presence.
The fact that this cytokine is active could be due to viruses, either active or dormant, being
present in the heart. Over time the expression of this cytokine even at this low level can cause
cardiac remodeling, resulting in complete heart failure if not diagnosed and treated properly.
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The other findings can be seen when the organ donor heart samples, 4D931 and 2B487 are
compared to the other samples, which were confirmed to have myocarditis or dilated
cardiomyopathy. Tnnt2, which functions by making a cardiac troponin protein that helps in heart
development, gave mixed expression profile results (28). The 2B487 sample had higher
expression levels than many of the samples, while 4D931 had less expression or no statistical
difference of expression when compared to each of the experimental trials (Figure 2). This
higher expression levels could be due to sample 2B487 being infected with a virus that has yet to
be tested or possibly having a higher level of viral infection when compared to the other samples.
Sample 4D931 had many of the same viruses present as the other 8 samples (Table 2),
suggesting that herpesviruses, Adenoviruses, and Epstein-Barr viruses can lead to an increase in
expression levels Tnnt2 regardless of whether the patient has myocarditis or not.
Rig-1 is a cytokine that is active in the innate immune system and is needed to find cells that
have become infected by a virus (29). It was observed that samples 63513, 48CAF, and BIF28
have this cytokine more upregulated than the two donor samples (Figure 1). This means it is
likely that one virus that is found in these three samples is not found in the others, leading to
these differences. In the future, it would be beneficial to screen these samples for even more
viruses to see which combination can cause this increased expression levels of Rig-1.
The TGF-β cytokine becomes activated during cell repair, and it can regulate inflammation (30).
It was seen that the cytokines fold change was near 0 for the two donor signals but higher in 5 of
the 8 experimental trials (Figure 1). It can be speculated that in these two samples the immune
system is actually attempting to decrease inflammation levels and repair the heart cells.
The final cytokine evaluated as NF-kB is a proinflammatory cytokine seen to trigger chronic
inflammation (31). Only two samples were seen to have higher fold changes than the two donors,
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48CAF and BIF28 (Figure 1). Once again, this supports the theory that the other experimental
samples were actually attempting to clear the virus from the heart when they needed a transplant.
Additionally, it was seen that BIF28 had higher cytokine expression levels meaning a full virus
panel should be run to make more correlations between the virus presence and this increase in
cytokines regardless of type.
In the next part of this study, the three heart layers were directly compared in three samples
632FD, 593836, and 48CAF, to evaluate the cytokine expression levels. For Interleukin-6, it was
seen for samples 632FD that there was no statistical difference for cytokine expression level in
the endocardium and epicardium, but both layers had a high expression when compared to the
myocardium (Figure 3). This was interesting because it shows that the viruses present can impact
multiple heart layers during myocarditis, a possible oversight in the current diagnostic methods.
For 632FD this trend continued throughout each of the cytokines evaluated for, with all three
heart levels being expressed at relatively high levels (Figure 3+4). The epicardium of this heart
sample was seen to never have the lowest expression levels statistically in any of the samples,
meaning in the future, this heart layer should be further evaluated to see if doctors are missing
key data when diagnosing myocarditis in patients.
In the 59386 sample, the epicardium was seen to have much higher expression levels when
compared to the other two layers, which were determined to be statistically similar in a majority
of the cases (Figure 4). Once again this represents a potential oversight in the current way to
diagnose myocarditis. It is currently thought that the myocardium is the main layer of the heart
being affected in many cases, but for this sample, it can be suggested that the epicardium has
even greater effects than the other two heart layers and should be further evaluated.
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For 48CAF there were little levels of expression seen for any of the three regions (Figure 3+4).
This means that it is likely that the immune system is not overly active in these samples
regardless of the heart layer chosen. In the future, this sample could be used to see which viruses
do not affect any of the heart layers in the sample.
Future Directions
Diagnosing heart inflammation relies on accurate identification of a pathogen behind cardiac
infection. In the future, it would be beneficial for many of the results seen in this thesis to be
optimized allowing for a more accurate identification. For example, during the viral
identification portion of this study, it was expected there would be one clear band seen which
would correspond to the viral genome present in the heart sample. In many of the images, there
was one clear band than many bands surrounding the clear band. This was likely due to the fact
that the PCR was not optimized. In order to overcome this, a new PCR can be done using
varying annealing temperatures. Then the resulting product can be run on a gel electrophoresis to
evaluate the proper temperature for that specific viral primer set. Doing this will allow for a
clearer band to be seen.
Improving the qPCR results would allow for more accurate expression profiles. Some data
points, especially those in the plate's bottom right, were calculated to have significant error bars
often stretching into negative expression levels. In the future, it would be beneficial for these
samples to be run in a different well on the plate so that more accurate data could be collected.
Similarly, all of my data was done with duplicates but to increase the confidence seen in my
data, it would be beneficial to run another trial so that the three data points can be compared
amongst each other allowing for more accurate conclusions to be made.
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Additionally, it would also be beneficial to send all of the samples out to be sequenced. Doing
sequencing would allow for one to search for the viral genome. For example, if one of the
samples was positive for Adenovirus, then it could have its genome searched for the known
Adenovirus genome. This gives more confidence in the conclusions the samples were positive
for the viruses evaluated for if it were found. Furthermore, the PCR sequences used can be
aligned to the viral genome sequenced allowing for any mutations to be uncovered. This data
would be beneficial in further understanding the mechanism of viral life cycles.
In the future, more qPCRs should be conducted using the three regions from each of the samples
obtained. This would allow for the research team to better evaluate the inflammation levels in all
three heart layers. Using this data will give more of an insight into how viruses affect the heart in
its entirety and if the current medical system is overlooking important information in the
diagnosis and treatment of myocarditis.
One other aspect that must be done in the future is the hematoxylin and eosin (H&E) staining on
each of the heart samples. This assay will allow for the visualization of cardiac injury, such as
infarcts, inflammatory cell infiltration and the rupture and necrosis of myocardial cells in each of
the samples. The amount of scar tissue can also be seen in each of the samples after they are
properly stained. This analysis is important as it would be tying together the identification of the
viruses and qPCR to evaluate what is happening in the heart in its entirety. This analysis will
give a definitive look into the heart, making conclusions with a higher degree of confidence.
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